{"id":15887,"date":"2012-06-07T01:12:23","date_gmt":"2012-06-07T01:12:23","guid":{"rendered":"http:\/\/www.eugenesis.com\/the-american-society-for-microbiology-honors-geoffrey-l-smith\/"},"modified":"2012-06-07T01:12:23","modified_gmt":"2012-06-07T01:12:23","slug":"the-american-society-for-microbiology-honors-geoffrey-l-smith","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/microbiology\/the-american-society-for-microbiology-honors-geoffrey-l-smith.php","title":{"rendered":"The American Society for Microbiology honors Geoffrey L. Smith"},"content":{"rendered":"<p><p>Public  release date: 6-Jun-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Garth Hogan    <a href=\"mailto:ghogan@asmusa.org\">ghogan@asmusa.org<\/a>    American    Society for Microbiology<\/p>\n<p>    Washington, DCJune 6, 2012 Geoffrey L. Smith, Ph.D., Wellcome    Trust Principal Research Fellow and Head, Department of    Pathology, University of Cambridge, and Fellow of Emmanuel    College, Cambridge, has been bestowed the 2012 GlaxoSmithKline    International Member of the Year Award, recognizing exemplary    leadership in the international microbiological community. His    nominator, Molly Hughes of the University of Virginia, says    Smith is \"internationally recognized as an outstanding    scientist due to his numerous original contributions to the    field of virology and the role he plays as a leader in a number    of scientific institutions.\"  <\/p>\n<p>    Smith received his B.Sc. in Microbiology and Biochemistry from    the University of Leeds, and his Ph.D. from the National    Institute for Medical Research, Mill Hill, London, while    working with influenza virus in the laboratory of Alan Hay. He    then held a Wellcome Trust Fellowship at the National Institute    for Medical Research, before becoming a postdoctoral fellow at    the National Institutes of Health in the laboratory of Bernard    Moss. There, together with Michael Mackett, he developed    vaccinia virus as an expression vector and established the use    of genetically engineered viruses as live vaccines, a principle    applied subsequently to other viruses and microorganisms.  <\/p>\n<p>    After returning to the United Kingdom, Smith continued working    with poxviruses at the University of Cambridge, the University    of Oxford, and the Imperial College London. He is now Head of    the Department of Pathology at the University of Cambridge,    where he studies the interactions of poxviruses (particularly    vaccinia virus) with the host cell and immune system. His    research group has contributed to the current understanding of    how these poxviruses replicate and spread and how they    interfere with innate immunity, findings that provide an    \"important contribution to not only the field of poxviruses,    but have also had widespread implications, particularly in the    field of immunology,\" says Hughes.  <\/p>\n<p>    \"Smith has played an important role in promoting microbiology    and advising on science policy both nationally and    internationally,\" says Michael Oldstone of Scripps Research    Institute. His sweeping service record demonstrates his    commitment to the international community. Smith is currently    President of the International Union of Microbiological    Societies, Chairman of the WHO Advisory Committee for Variola    Virus (smallpox) Research, Chairman of the Royal Society    Committee for Scientific Aspects of International Security, a    member of the Royal Society Science Policy Advisory Group and    the UK Defence Scientific Advisory Council, and a Governor of    the Lister Institute of Preventive Medicine. He is a    Corresponding Member of the Gesellschaft fr Virologie, and a    Fellow of the Academy of Medical Sciences, the Institute of    Biology, the European Academy of Microbiology, the German    National Academy of Sciences (Leopoldina), and the Royal    Society. In 2003 he became Editor-in-Chief of the Journal of    General Virology. He was awarded the Feldberg Foundation Prize    in Medical and Biological Science to promote Anglo-German    Friendship.  <\/p>\n<p>    \"Smith has been a tireless contributor to the science of    microbiology in general and virology in particular throughout    his career. His ability to maintain an enormous and global    variety of research, teaching, and service activities and do    each expertly is awe-inspiring,\" says Richard Condit,    University of Florida.  <\/p>\n<p>    ###  <\/p>\n<p>    To view Dr. Smith's biosketch, please visit: <a href=\"http:\/\/www.asm.org\/index.php\/awards-grants\/current-glaxosmithkline-international-member-of-the-year-award-laureate.html\" rel=\"nofollow\">http:\/\/www.asm.org\/index.php\/awards-grants\/current-glaxosmithkline-international-member-of-the-year-award-laureate.html<\/a>  <\/p>\n<p>    The GlaxoSmithKline International Member of the Year Award will    be presented during the 112th General Meeting of the ASM, June    16 - 19, 2012 in San Francisco, California. ASM is the world's    oldest and largest life science organization and has more than    40,000 members worldwide. ASM's mission is to advance the    microbiological sciences and promote the use of scientific    knowledge for improved health and economic and environmental    wellbeing.  <\/p>\n<\/p>\n<p>Here is the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-06\/asfm-tas_19060612.php\" title=\"The American Society for Microbiology honors Geoffrey L. Smith\">The American Society for Microbiology honors Geoffrey L. Smith<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 6-Jun-2012 [ | E-mail | Share ] Contact: Garth Hogan <a href=\"mailto:ghogan@asmusa.org\">ghogan@asmusa.org<\/a> American Society for Microbiology Washington, DCJune 6, 2012 Geoffrey L.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/microbiology\/the-american-society-for-microbiology-honors-geoffrey-l-smith.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577473],"tags":[],"class_list":["post-15887","post","type-post","status-publish","format-standard","hentry","category-microbiology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/15887"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=15887"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/15887\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=15887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=15887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=15887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}